Provided by Tiger Fintech (Singapore) Pte. Ltd.

10x Genomics, Inc.

12.15
-0.3000-2.41%
Post-market: 12.260.1100+0.91%18:19 EDT
Volume:1.89M
Turnover:23.13M
Market Cap:1.50B
PE:-9.38
High:12.66
Open:12.60
Low:12.06
Close:12.45
Loading ...

Leerink Partners Reaffirms Their Hold Rating on 10x Genomics (TXG)

TIPRANKS
·
Yesterday

10x Genomics and A*STAR GIS Launch TISHUMAP Study to Uncover Novel Cancer and Inflammatory Disease Therapies

Reuters
·
17 Jul

10x Genomics Is Maintained at Neutral by B of A Securities

Dow Jones
·
27 Jun

10x Genomics Is Maintained at Overweight by Barclays

Dow Jones
·
24 Jun

10x Genomics Inc. Conducted Annual Stockholders Meeting

Reuters
·
06 Jun

Cathie Wood’s ARK Investment buys 342K shares of 10x Genomics today

TIPRANKS
·
31 May

Benjamin J. Hindson, Officer and Director, Reports Disposal of Common Shares in 10x Genomics Inc

Reuters
·
28 May

CFO Adam Taich Reports Disposal of Common Shares of 10x Genomics Inc

Reuters
·
28 May

Trump Funding Cuts Are Roiling Science. These Stocks May Be Hardest Hit. -- Barrons.com

Dow Jones
·
22 May

10x Genomics Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
19 May

Analysts Offer Insights on Healthcare Companies: scPharmaceuticals (SCPH), 10x Genomics (TXG) and Kura Oncology (KURA)

TIPRANKS
·
19 May

Stock Track | 10x Genomics Plummets 5.08% Following Patent Dispute Settlement with Bruker

Stock Track
·
16 May

10x Genomics Price Target Maintained With a $14.00/Share by Stephens & Co.

Dow Jones
·
15 May

Stock Track | 10x Genomics Soars 5.48% After Hours on $68 Million Patent Settlement with Bruker

Stock Track
·
15 May

10x Genomics Reaches $68 Million Patent Settlement With Bruker

MT Newswires Live
·
15 May

10x Genomics: Expects Bruker to Pay $68 Mln in Equal Qtrly Installments Between Q3 O 2025 & Q2 2026

THOMSON REUTERS
·
15 May

10x Genomics Announces Patent Litigation Settlement Agreement With Bruker

THOMSON REUTERS
·
15 May

10x Genomics- Expects Bruker Will Pay $68 Mln in Equal Quarterly Installments Between Q3 of 2025 and Q2 of 2026

THOMSON REUTERS
·
15 May

Stock Track | 10x Genomics Plummets 5.08% Following Patent Dispute Settlement with Bruker

Stock Track
·
15 May

Stock Track | 10x Genomics Plummets 5.08% Following Patent Dispute Settlement with Bruker

Stock Track
·
15 May